Experience

Enzo Biochem Inc

• United States
• Biotechnology Research
• 1 - 100 Employee

• Interim Chief Financial Officer

  • Nov 2022 - Present

  Provided financial and executive guidance in the Company’s strategic initiatives; advised Company on all financial and compliance matters pertaining to the recently announced $113 million asset purchase agreement of the clinical lab division; Communicated and collaborated directly with investment bankers, financial advisors and the Company’s Board of Directors; Participated in presentations and meetings with potential buyers, supported the bidding process, reviewed the letters of intent, and conducted extensive due diligence. Managed a team of 30 accounting, finance and billing professionals. Responsible for all global accounting and finance functions, including, but not limited to, revenue recognition, billing and collections, payables and expense management, financial planning and analysis, month-end closing and consolidation processes, SEC reporting, tax support, and SOX compliance. Engaged with institutional and retail shareholders as well as equity analysts. Responsible for ensuring accurate and timely SEC filings, with extensive audit discussions, accounting standard review, and reports to Audit Committee. Lead preparation of proxy materials and active participation in annual shareholders meeting. Preparation of press releases and scripts with lead role in earnings calls with Chief Executive Officer. Identified and executed on a full range of debt and equity financing options to position the Company for growth, including any required SEC documentation. Supported operational and legal teams with regards to financial aspects in collaboration with C-level executives. Show less



Enzo Clinical Labs

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Vice President Finance

  • Sep 2022 - Nov 2022

• Senior Director of Finance

  • Dec 2017 - Sep 2022

  Responsible for all finance functions including but not limited to, revenue recognition and billing, expense management, financial reporting and analysis, cash management and accounting operations. Further accountable for budgeting and forecasting, performance management metrics, process improvements, and enhancements to internal controls.



Pall Corporation

• United States
• Manufacturing
• 700 & Above Employee

• Accounting Director

  • Jul 2013 - Aug 2017

  Project Manager for Pall Corporation's implementation of new revenue recognition standard, ASC 606. Responsible for all aspects of SOX controls, streamlined global efforts across internal and external teams, enabling the finance transformation. Effectively integrated SOX program subsequent to Danaher acquisition. Oversight of Global Risk Management. Performed Corporate FP&A responsibilities.

• Director of Record to Report

  • Nov 2011 - Jun 2013

  Directed Record to Report activities for Pall Corporation's North American Shared Services center. Managed a team of 15 professionals to support 18 reporting entities. Supported the Company's SAP implementation. Achieved the "5 Day Close" objectives five months post SAP implementation by standardizing process and implementing a risk based approach. Managed project to transition Record to Report and Accounts Payable activities to Malaysia. Performed controllership activities and oversight for parent company reporting entity. Show less

• Accounting Manager

  • Jan 2008 - Oct 2011

  Obtained full controlling responsibility for parent company, while transitioning to a more supervisory and process owner role. Supported planning and execution of the centralization of transactional Finance processes to a Shared Services center. Selected as lead Finance Subject Matter Expert for SAP implementation.

• Accounting Supervisor

  • Sep 2006 - Jan 2008

• Senior Accountant

  • Aug 2003 - Sep 2006



AVZ

• Financial Services
• 1 - 100 Employee

• Senior Accountant

  • Sep 2002 - Aug 2003

• Staff Accountant

  • Jan 2001 - Sep 2002

• Internal Auditor

  • Jun 1999 - Jan 2001